The Effect of Perineural Administration of Dexmedetomidine on Narcotic Consumption and Pain Intensity in Patients Undergoing Femoral Shaft Fracture Surgery; A Randomized Single-Blind Clinical Trial

다국어 초록 (Multilingual Abstract)

Dexmedetomidine is a selective a-2 adrenoceptor agonist with anxiolytic, sedative, and analgesic properties that prolongs analgesia and decreases opioid-related side effects when used in neuraxial and perineural areas as a local anesthetics adjuvant. The current study was designed to evaluate the effects of a single perineural administration of dexmedetomidine without local anesthetics on narcotic consumption and pain intensity in patients with femoral shaft fractures undergoing surgery. This prospective randomized single-blind clinical trial was conducted in patients undergoing femoral fracture shaft surgery. Based on block permuted randomization, the patients were randomly divided into intervention and control groups. The intervention group received 100 mg dexmedetomidine, for a femoral nerve block without any local anesthetics. Total intraoperative opioid consumption, postoperative opioid consumption, visual analogue score (VAS) for pain, and hemodynamic parameters were recorded and compared. Finally the data from 60 patients with a mean age of 30.4±12.3 were analyzed (90% male). There were no significant differences between the baseline characteristics of the two groups (p>0.05). The mean total consumption of narcotics was reduced during induction and maintenance of anesthesia in the intervention group (p<0.05). The amount of postoperative narcotics required showed a significant difference in the intervention group compared with the control group (p<0.05). It is likely that perineural administration of dexmedetomidine significantly not only reduced intra and postoperative narcotic requirement but also decreased postoperative pain intensity in patients undergoing femoral shaft surgery. Femoral blockade by dexmedetomidine can provide excellent analgesia while minimizing the side-effects of opioids.

참고문헌 (Reference)

1 Fletcher AK, "Three-in-one femoral nerve block as analgesia for fractured neck of femur in the emergency department: a randomized, controlled trial" 41 : 227-233, 2003

2 Sen S, "The effect of dexmedetomidine infusion on propofol requirement for maintenance of optimum depth of anaesthesia during elective spine surgery" 57 : 358-363, 2013

3 Mason KP, "Review article : Dexmedetomidine in children : current knowledge and future applications" 113 : 1129-1142, 2011

4 Ohtani N, "Recovery profiles from dexmedetomidine as a general anesthetic adjuvant in patients undergoing lower abdominal surgery" 107 : 1871-1874, 2008

5 Rancourt MP, "Posterior tibial nerve sensory blockade duration prolonged by adding dexmedetomidine to ropivacaine" 115 : 958-962, 2012

6 Brummett CM, "Perineural dexmedetomidine provides an increased duration of analgesia to a thermal stimulus when compared with a systemic control in a rat sciatic nerve block" 35 : 427-431, 2010

7 Brummett CM, "Perineural dexmedetomidine added to ropivacaine for sciatic nerve block in rats prolongs the duration of analgesia by blocking the hyperpolarization-activated cation current" 115 : 836-843, 2011

8 Joshi GP, "Multimodal analgesia techniques and postoperative rehabilitation" 23 : 185-202, 2005

9 Burow BK, "Metabolic acidosis associated with propofol in the absence of other causative factors" 101 : 239-241, 2004

10 Williams BA, "Femoral-sciatic nerve blocks for complex outpatient knee surgery are associated with less postoperative pain before same-day discharge: a review of 1,200 consecutive cases from the period 1996-1999" 98 : 1206-1213, 2003

11 Mulroy MF, "Femoral nerve block with 0.25% or 0.5% bupivacaine improves postoperative analgesia following outpatient arthroscopic anterior cruciate ligament repair" 26 : 24-29, 2001

12 Wang PH, "Effects of topical corticosteroids on the sciatic nerve : an experimental study to adduce the safety in treating carpal tunnel syndrome" 36 : 236-243, 2011

13 Ali Erdogan M, "Effects of perineural administration of dexmedetomidine in combination with levobupivacaine in a rat sciatic nerve block" 74 : 74-78, 2013

14 Mirkheshti A, "Effects of dexmedetomidine versus ketorolac as local anesthetic adjuvants on the onset and duration of infraclavicular brachial plexus block" 4 : e17620-, 2014

15 Blaudszun G, "Effect of perioperative systemic α2 agonists on postoperative morphine consumption and pain intensity : systematic review and meta-analysis of randomized controlled trials" 116 : 1312-1322, 2012

16 Lin TF, "Effect of combining dexmedetomidine and morphine for intravenous patient-controlled analgesia" 102 : 117-122, 2009

17 Abdel-Aleem M, "Effect of coadministration of dexamethasone with intrathecal morphine on postoperative outcomes after cesarean delivery" 116 : 158-161, 2012

18 Wu HH, "Does dexmedetomidine as a neuraxial adjuvant facilitate better anesthesia and analgesia? A systematic review and meta-analysis" 9 : e93114-, 2014

19 Le Guen M, "Dexmedetomidine reduces propofol and remifentanil requirements during bispectral index-guided closed-loop anesthesia: a double-blind, placebo-controlled trial" 118 : 946-955, 2014

20 Segal IS, "Dexmedetomidine diminishes halothane anesthetic requirements in rats through a postsynaptic alpha 2 adrenergic receptor" 69 : 818-823, 1988

21 Esmaoglu A, "Dexmedetomidine added to levobupivacaine prolongs axillary brachial plexus block" 111 : 1548-1551, 2010

22 Gertler R, "Dexmedetomidine : a novel sedative-analgesic agent" 14 : 13-21, 2001

23 Pöpping DM, "Clonidine as an adjuvant to local anesthetics for peripheral nerve and plexus blocks : a meta-analysis of randomized trials" 111 : 406-415, 2009